Publications by authors named "KA Hamacher"

Claim this Profile
P
Possible axonal regrowth in late recovery from the minimally conscious state.
Henning U Voss, Aziz M Uluğ, Jonathan P Dyke, Richard Watts, Erik J Kobylarz, Klaus A Hamacher

J Clin Invest· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of GATE Monte Carlo simulations of the GE Advance/Discovery LS PET scanners.
C Ross Schmidtlein, Assen S Kirov, Sadek A Nehmeh, Yusuf E Erdi, John L Humm, Klaus A Hamacher

Med Phys· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of myelotoxicity based on bone marrow radiation-absorbed dose: radioimmunotherapy studies using 90Y- and 177Lu-labeled J591 antibodies specific for prostate-specific membrane antigen.
Shankar Vallabhajosula, Stanley J Goldsmith, Klaus A Hamacher, Lale Kostakoglu, Shota Konishi

J Nucl Med· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu?
Shankar Vallabhajosula, Ichei Kuji, Klaus A Hamacher, Shota Konishi, Lale Kostakoglu

J Nucl Med· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted alpha particle immunotherapy for myeloid leukemia.
Joseph G Jurcic, Steven M Larson, George Sgouros, Michael R McDevitt, Ronald D Finn, Klaus A Hamacher

Blood· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Theoretical estimation of absorbed dose to organs in radioimmunotherapy using radionuclides with multiple unstable daughters.
K A Hamacher, G Sgouros

Med Phys· September 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular dose conversion factors for alpha-particle--emitting radionuclides of interest in radionuclide therapy.
K A Hamacher, R B Den, E I Den, G Sgouros

J Nucl Med· August 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response of LNCaP spheroids after treatment with an alpha-particle emitter (213Bi)-labeled anti-prostate-specific membrane antigen antibody (J591).
A M Ballangrud, W H Yang, D E Charlton, M R McDevitt, K A Hamacher

Cancer Res· March 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parametric images of antibody pharmacokinetics in Bi213-HuM195 therapy of leukemia.
K S Kolbert, K A Hamacher, J G Jurcic, D A Scheinberg, S M Larson

J Nucl Med· January 2001

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A schema for estimating absorbed dose to organs following the administration of radionuclides with multiple unstable daughters: a matrix approach.
K A Hamacher, G Sgouros

Med Phys· December 1999

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiphoton exchange amplitudes observed by neutron interferometry.
J Summhammer, KA Hamacher, H Kaiser, H Weinfurter, DL Jacobson

Phys Rev Lett· October 1995

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis